North Carolina Central University
Dr. Yang received his medical training from Luoyang Medical College, followed by a M.S. Pathophysiology from the Institute of Basic Medical Sciences in Beijing, China. He obtained his Ph.D. degree in Microbiology/Immunology from RFUMS/The Chicago Medical School and postdoctoral training at Northwestern University. Prior to his arrival at the North Carolina Research Campus, he was an Associate Professor of Pathology at the University of Oklahoma Health Sciences Center. Dr. Yang was a recipient of the Career Development Award from the Department of Defense Breast Cancer Research Program. He is also an American Cancer Society Research Scholar.
Dr. Yang's research is focused on molecular and cellular cancer biology. His work has explored E2F-1 mediated oncogenicity; the roles of granyzme and caspases in breast carcinogenesis and therapeutic resistance; communication between p53 and p73 proteins in breast cancer cells; crosstalk between ER and erbB-2 pathways, and phytoestrogen modulated breast cancer prevention. Dr. Yang's current research is on breast cancer etiology and prevention with emphases on the modulation of hormone-growth factor crosstalk, apoptosis and mammary stem cell reprogramming by various genetic and environmental factors.